Forskning ved Københavns Universitet - Københavns Universitet

Forside

Antidiabetika, insulinresistens og hjerte-kar-sygdom hos patienter med type 2-diabetes

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • Bianca Hemmingsen
  • Søren S Lund
  • Allan Vaag
This article reviews the current evidence of effects on cardiovascular disease (CVD) of anti-diabetic treatment which exert their effect by increasing the insulin sensitivity in patients with type 2 diabetes (T2D). In overweight T2D patients, it has been demonstrated that metformin reduces the CVD risk. The effect of glitazones on CVD is uncertain. There is insufficient evidence to support a protective effect on CVD of lowering blood-glucose per se. In contrast, lowering blood glucose appears to decrease the risk of microvascular complications.
Udgivelsesdato: 2009-May-4
OriginalsprogDansk
TidsskriftUgeskrift for læger
Vol/bind171
Udgave nummer19
Sider (fra-til)1598-602
Antal sider4
ISSN0041-5782
StatusUdgivet - 2009

ID: 19979307